These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Ataractic treatment in psychiatry and general medicine. Overview of drugs. 2]. Hertrich O Fortschr Med; 1983 May; 101(20):943-5. PubMed ID: 6873848 [No Abstract] [Full Text] [Related]
23. [On the mechanism of action of psychotropic agents (fast and slow compoents of their pychopharmacologic effect)]. Banshchikov VM; Berezin FB Zh Nevropatol Psikhiatr Im S S Korsakova; 1966; 66(10):1561-5. PubMed ID: 6000320 [No Abstract] [Full Text] [Related]
25. [Utilization of tranquilizers in institutions]. Chanoit P Laval Med; 1970 Jun; 41(6):805-13. PubMed ID: 5509702 [No Abstract] [Full Text] [Related]
26. Czechoslovak psychotropic drugs: their clinical use. Vinar O Act Nerv Super (Praha); 1973 Aug; 15(3):180-5. PubMed ID: 4769141 [No Abstract] [Full Text] [Related]
27. [On the pharmacology of psychotropic drugs used in child psychiatry]. Taeschler M; Loew D Ser Paedopsychiatr; 1965; (1):40-74. PubMed ID: 5321342 [No Abstract] [Full Text] [Related]
28. [Effect of psychotropic drugs on cholinesterase activity in blood serum of mental patients]. Pietruszewska I; Urbanek B Acta Pol Pharm; 1968; 25(2):201-6. PubMed ID: 5662912 [No Abstract] [Full Text] [Related]
29. [Qualitative clinical study of psychotropic drugs and time factors in chemotherapy]. Benoit JC; Leroy C Evol Psychiatr (Paris); 1968; 33(4):687-706. PubMed ID: 5713801 [No Abstract] [Full Text] [Related]
30. [Prolonged neurologic syndromes due to neuroleptic drugs and their treatment]. Deniker P; Ginestet D Ann Med Interne (Paris); 1972; 123(8):787-9. PubMed ID: 4642195 [No Abstract] [Full Text] [Related]
31. [Extension of therapeutic possibilities by a new tranquilizer]. Leube H Arzneimittelforschung; 1968 Dec; 18(12):1566-8. PubMed ID: 5756250 [No Abstract] [Full Text] [Related]
32. Therapeutic problems with psychotropic drugs: some epidemiological considerations. Shepherd M Psychiatr Neurol Neurochir; 1969; 72(6):503-6. PubMed ID: 5369241 [No Abstract] [Full Text] [Related]
33. Electroencephalographic variations following anti-psychotic drug treatment. (Diagnostic and prognostic significance). Dasberg H; Robinson S Dis Nerv Syst; 1971 Jul; 32(7):472-8. PubMed ID: 5570415 [No Abstract] [Full Text] [Related]
34. Use and abuse of psychotropic drugs. Weintraub W Mod Treat; 1969 Jul; 6(4):793-805. PubMed ID: 5810674 [No Abstract] [Full Text] [Related]
35. [Psychopathologic symptomatology and the use of psychotropic drugs in surgical vascular pathology of the brain]. Chebysheva LN; Lysachev AG Zh Vopr Neirokhir Im N N Burdenko; 1982; (3):11-5. PubMed ID: 7124234 [No Abstract] [Full Text] [Related]
37. [Does the use of neuroleptics and drugs for mood disorders have any special risks in children?]. Dugas M; Guériot C; Vélin J; Porot D; Calvet S Ann Med Interne (Paris); 1972; 123(8):801-4. PubMed ID: 4642197 [No Abstract] [Full Text] [Related]
38. [The therapeutic significance of muscle-relaxing psychotropic drugs in anxiety states. Clinical trial of a new benzodiazepine derivative, oxazepam]. Madalena JC J Bras Psiquiatr; 1965; 14(3):245-75. PubMed ID: 5873213 [No Abstract] [Full Text] [Related]
39. The clinical use of central depressant: muscle relaxants and tranquilizers in musculoskeletal disorders. Owens RE J Am Podiatry Assoc; 1976 Sep; 66(9):671-1. PubMed ID: 965690 [No Abstract] [Full Text] [Related]
40. Psychotropic drugs prescribed in three Prague districts. Stika L; Vinar O Act Nerv Super (Praha); 1973 Aug; 15(3):161-2. PubMed ID: 4769125 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]